U.S. Beverage Stock News

If you are wondering whether RPC at US$6.83 is priced attractively or not, the starting point is understanding what the current market price might be implying about its future. Over the short term, the stock has returned 4.8% in the last 7 days, 12.0% over 30 days, 23.5% year to date, 28.6% over 1 year, and 38.1% over 5 years, while the 3 year return sits at a 4.0% decline. Recent coverage around RPC has focused on how investors are reassessing energy service providers, with attention on...

Jack Henry & Associates (NasdaqGS:JKHY) received the “Small Business Payments Solution of the Year” award at the FinTech Breakthrough Awards for its Tap2Local product. The recognition focuses on Tap2Local, a cloud-native payments solution designed for small business clients of banks and credit unions. For investors watching NasdaqGS:JKHY, this award offers insight into how the company is positioning itself within digital payments for community and regional financial institutions. Tap2Local...

Investors may be wondering whether CONMED's share price around US$35.94 reflects its true worth, or if the market has pushed it too far in one direction. The stock has seen weak recent returns, with a 3.6% decline over the last week, 20.4% over the last month, 11.3% year to date, and 39.3% over the past year. These moves can reshape how investors think about both risk and potential opportunity. Recent coverage has focused on CONMED as part of a broader look at medical equipment names, with...

To understand whether Waystar Holding at US$24.07 offers value or just looks cheap on the surface, you need to weigh the recent share performance against the fundamentals. Over the last week the stock returned 0.4% lower, over the last month it is 6.7% lower, and over the year it is 23.3% lower year to date and 35.8% lower over 1 year, which may signal that expectations and risk perceptions have shifted. Recent coverage has focused on Waystar Holding's position in healthcare services and...

In recent analyses, S&T Bancorp’s net interest income was found to have grown more slowly than the broader banking industry over the past five years and is now expected by sell-side analysts to decline by 5.3% in the coming 12 months, while earnings per share have fallen by 3.3% annually over the last two years on flat revenue. This combination of slowing core lending income and shrinking earnings, despite stable top-line performance, highlights ongoing pressure on the bank’s profitability...

Ryerson Holding (RYZ) has drawn investor attention after a period of weaker share performance, with the stock down over the past month and past 3 months despite its sizeable US metals processing footprint. See our latest analysis for Ryerson Holding. The 30 day share price return of 28.71% and 90 day return of 23.69% point to fading momentum. Meanwhile, the 1 year total shareholder return of 10.06% contrasts with a weaker 3 year total shareholder return of 37.54%, suggesting investors are...

Wondering if Alliant Energy’s current share price reflects its real worth, or if you might be paying too much for a regulated utility stock right now? The stock last closed at US$68.71, with a 7 day return of a 5.6% decline, a 30 day return of a 1.2% decline, a 1 year return of 12.5%, a 3 year return of 46.9%, and a 5 year return of 49.7%. These moves have come as investors continue to reassess regulated utilities as an income and stability option. Alliant Energy has attracted attention as...

Aveanna Healthcare Holdings (NasdaqGS:AVAH) announced the acquisition of Family First Homecare. The deal is intended to strengthen Aveanna's position in Florida and widen its geographic reach. The company also outlined a transformation that increased preferred payer agreements and set new M&A priorities for 2026. Aveanna Healthcare focuses on home based care services, an area many investors watch as care delivery shifts closer to the home. By adding Family First Homecare, the company is...

If you are wondering whether Enerpac Tool Group at around US$35.97 is a bargain, fairly priced, or looking stretched, this article walks through the key valuation angles to help you frame that question clearly. The stock is roughly flat over the last week with a 0.3% return. That sits against a 14.7% decline over the last month and a 14.8% decline over the last year, even as the 3 year and 5 year returns are 37.7% and 38.0% respectively. Recent coverage has focused on how Enerpac Tool Group...

Wondering if First Mid Bancshares at around US$39.44 is giving you fair value or a potential bargain? This article breaks down what the current price might be implying about the business. The stock is roughly flat over the last week at 0.1%, has seen a 9.2% decline over the past month, yet is still up 2.1% year to date and 15.5% over the last year, with a 59.7% return across three years and 0.4% over five years. Recent coverage around regional banks has focused on how share prices react to...

Wondering if Rezolve AI at US$2.53 is still priced for a turnaround or already baking in the story? This breakdown will help you frame what the current market price may be implying. The stock has been volatile recently, with a 5.9% decline over the last week, a 13.5% gain over the last month, an 11.8% year to date drop, and a 53.3% return over the past year, all set against a 74.9% decline over three years. Recent coverage has focused on Rezolve AI as an emerging player in the listed AI...

Starwood Real Estate Income Trust (OTCPK:SWDR) has posted its FY 2025 numbers with fourth quarter revenue of US$402.8 million, a basic EPS loss of US$0.39, and funds from operations of US$4.4 million in the red, setting the tone for a year where trailing twelve month revenue reached about US$1.6 billion alongside a net loss of US$691.6 million. Over recent quarters, revenue has moved in a tight band between US$389.7 million and US$420.2 million while EPS has remained in loss territory. As a...

IDT Corporation recently reported past second-quarter fiscal 2026 results showing higher sales and net income year-over-year, alongside improved earnings per share from continuing operations. The board also raised the annual dividend from US$0.24 to US$0.28 per share, signaling confidence in the company’s cash generation and capital return plans. With this dividend increase as a starting point, we’ll now examine how these developments could influence IDT’s broader investment narrative. AI is...

In March 2026, Walgreens announced a nationwide initiative with Exact Sciences and Workflow Services that lets eligible, average-risk customers request the FDA-approved, at-home Cologuard colorectal cancer screening test through its pharmacies, aiming to close care gaps with pharmacist-led services integrated into store workflows. At the same time, Exact Sciences highlighted new data on its Oncodetect molecular residual disease test and Cancerguard multi-cancer early detection assay at the...

Taysha Gene Therapies (NasdaqGS:TSHA) received FDA Breakthrough Therapy designation for TSHA-102 in Rett syndrome. The company reported a 100% patient response rate in pivotal Phase I/II data for TSHA-102. Regulators aligned with Taysha on pivotal trial designs for its lead Rett syndrome program. Taysha added a key commercial hire as it prepares for potential TSHA-102 commercialization. Taysha Gene Therapies, trading at $4.4 per share, has been drawing attention as its 1 year return stands...

Ambarella (NasdaqGS:AMBA) used a recent industry conference to outline a faster push into Edge AI products. The company highlighted a major shift in its revenue mix, new sales efforts aimed at smaller customers, and progress on a semi custom chip. Management also disclosed work on an upcoming two nanometer chip, signaling a move to more advanced manufacturing nodes. Ambarella, trading at about $54.02, has seen a mixed share price record, with a 3.3% gain over the past week but a 28.1%...

Yiren Digital (YRD) is back in focus after Q4 2025 results showed revenue of CN¥957.63 million, a net loss of CN¥882.16 million, and a temporary suspension of its cash dividend for the second half of 2025. See our latest analysis for Yiren Digital. The earnings miss and dividend suspension appear to have weighed heavily on sentiment, with a 7 day share price return of 44.19% and a 1 year total shareholder return of 69.72%. The 3 year total shareholder return remains slightly positive, which...

HeartFlow (NasdaqGS:HTFL) reported landmark real world data at ACC 2026 showing its AI Plaque Analysis as a leading independent predictor for cardiovascular risk stratification. The Plaque Analysis data is linked with improved patient outcomes and substantial cost savings in coronary artery disease management. The company launched the large scale NAVIGATE PCI Registry to study its AI driven PCI Navigator tool ahead of commercial release. HeartFlow’s AI platform is now backed by FDA cleared...

FedEx Q3 2026 Earnings Snapshot FedEx (FDX) has put up another solid set of quarterly numbers, with Q3 2026 revenue at US$24.0 billion and basic EPS of US$4.47, giving investors a clear look at how the business is performing through the current fiscal year. The company has seen revenue move from US$21.2 billion in Q3 2025 to US$24.0 billion in Q3 2026, while quarterly basic EPS shifted from US$3.78 to US$4.47 over the same period. The trailing twelve month net profit margin now sits at 4.9%...

Hexcel is collaborating through the ECCA initiative with James Cropper to develop aerospace grade composites using recycled carbon fibre, supporting circularity and lower waste in advanced materials. The company is also a key materials supplier for Dassault Aviation's Falcon 10X program, which has reached an important aircraft rollout milestone. These developments highlight Hexcel's role in both sustainable material solutions and next generation business jets across the aerospace...

JinkoSolar Holding (NYSE:JKS) has entered a multi year supply agreement with Nextpower for U.S. manufactured steel module frames. The partnership centers on steel frames and deeper localization of JinkoSolar's U.S. solar module supply chain. The agreement supports JinkoSolar's efforts to source key components domestically and align with U.S. solar infrastructure priorities. For investors tracking NYSE:JKS, this move comes with the stock at around $23.4 and a mixed performance profile...

ArcBest's board is urging shareholders to vote against a climate related proposal ahead of the upcoming annual meeting. The proposal calls for the company to set greenhouse gas emission reduction targets. The board's stance highlights tension between management and some shareholders over environmental priorities and disclosure. ArcBest (NasdaqGS:ARCB) enters this vote with a current share price of $87.58 and a mixed recent return profile. The stock is up 3.2% over the past week and 13.5%...

United States Antimony (UAMY) has just reported its FY 2025 numbers, with Q4 revenue of about US$13.0 million and a basic EPS loss of roughly US$0.002. Trailing 12 month figures show revenue at around US$39.3 million and a basic EPS loss of about US$0.035. Over the past six reported quarters, revenue has moved from roughly US$2.6 million in Q3 2024 to US$13.0 million in Q4 2025, with quarterly EPS ranging between a profit of about US$0.0048 and a loss of roughly US$0.039. This sets up a...

Firefly Aerospace (FLY) just closed FY 2025 with fourth quarter revenue of US$57.7 million and a basic EPS loss of US$0.26, alongside trailing twelve month revenue of US$159.9 million and a TTM EPS loss of US$4.83, versus very large revenue growth of 163% over the past year. Over recent quarters, the company has seen revenue move from US$9.0 million in Q4 2024 to US$57.7 million in Q4 2025 while quarterly basic EPS losses shifted from US$7.86 to US$0.26. This leaves investors weighing robust...